SWP
CHRS icon

Stratos Wealth Partners’s Coherus Oncology CHRS Stock Holding History

Stratos Wealth Partners’s Portfolio CHRS Stock Details CHRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$22.6K Hold
16,131
– – ﹤0.01% 1685
2026
Q1 		$27.3K Hold
16,131
– – ﹤0.01% 1611
2025
Q4 		$22.9K Sell
16,131
-18
-0.1% -$26 ﹤0.01% 1581
2025
Q3 		$26.5K Hold
16,149
– – ﹤0.01% 1541
2025
Q2 		$11.8K Hold
16,149
– – ﹤0.01% 1416
2025
Q1 		$13K Sell
16,149
-307
-2% -$353 ﹤0.01% 1353
2024
Q4 		$22.7K Buy
+16,456
New +$18.5K ﹤0.01% 1441

Other funds holding CHRS

TGY2IT
Timothy G. Youngquist 2020 Irrevocable Trust Fort Myers, Florida $510M AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.15B AUM 13.14% 1-Year Est. Return

Stratos Wealth Partners's CHRS Position: Q2 2026 in Review

Stratos Wealth Partners held its Coherus Oncology (CHRS) position steady in Q2 2026 at 16,131 shares worth $22.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1685.

Stratos Wealth Partners first reported a position in CHRS in Q4 2024 and has held it in 7 quarters since. The position peaked at $27.3K in Q1 2026. 146 funds tracked by Wall St. Rank hold CHRS as of Q2 2026.

  • Stratos Wealth Partners held 16,131 shares of Coherus Oncology worth $22.6K as of Q2 2026.
  • Stratos Wealth Partners left its Coherus Oncology share count unchanged in Q2 2026.
  • Coherus Oncology made up ﹤0.01% of Stratos Wealth Partners's portfolio in Q2 2026, its #1685 holding.
  • Stratos Wealth Partners first reported a position in Coherus Oncology in Q4 2024 and has held it in 7 quarters since.
  • Stratos Wealth Partners's Coherus Oncology position peaked at $27.3K in Q1 2026.
  • 146 funds tracked by Wall St. Rank held Coherus Oncology as of Q2 2026.

Based on Stratos Wealth Partners's 13F filing for Q2 2026, filed 11 Aug 2026.